Omnicell Inc. (OMCL)
Omnicell Inc. (OMCL) Stock Price, Analysis & Data
| Bid | 26.28 |
| Market Cap | 1.66B |
| Revenue (ttm) | 1.25B |
| Net Income (ttm) | 39.08M |
| Beta | 0.97 |
| EPS (ttm) | 0.84 |
| PE Ratio (ttm) | 43.42 |
| Forward PE | 17.45 |
| P/B (ttm) | 1.29 |
| P/S (ttm) | 1.33 |
| Earnings Date | Oct 29, 2026 |
| Ask | 46.46 |
| Volume | 148,407 |
| Avg. Volume (20D) | 718,674 |
| Open | 36.65 |
| Previous Close | 36.86 |
| Day's Range | 35.95 - 36.76 |
| 52-Week Range | 29.06 - 55.00 |
| Analyst | Strong Buy |
| Price Target | 60 (64.47%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About OMCL
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also p...
Financial Performance
In 2025, Omnicell's revenue was 1.18B, an increase of 6.53% compared to the previous year's 1.11B. Earnings were 2.05M, a decrease of -83.62%.
Financial StatementsAnalyst Forecast
According to 7 analyst ratings, the average rating for OMCL stock is "Strong Buy". The 12-month stock price forecast is 60, which is upside of 64.47% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
